Sessions

Jul 13-14, 2023    Amsterdam, Netherlands

2nd International Conference on

Digestive and Metabolic Disease

Sessions

Current and prospective treatments for diarrhea-associated irritable bowel syndrome

Irritable bowel syndrome (IBS) is a multifactorial illness characterised by irregular bowel movements and recurring abdominal pain or discomfort. In the developed world, 10 to 20 percent of people are affected by it, with IBS and diarrhoea affecting roughly one-third of those individuals (IBS-D).

The role of lifestyle-related treatments for IBS

Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal condition defined by stomach pain or discomfort in the absence of structural, significant inflammatory, or biochemical abnormalities, as well as symptoms of disturbed bowel habit (diarrhoea, constipation, or both). These symptoms can have a major impact on quality of life, work productivity, and the consumption of health-care resources.

Small bowel haemorrhage diagnosis and management: An update on diagnostic and therapeutic tools

Diagnosis and management of small bowel (SB) bleeding remain a challenging problem faced by gastroenterologists, both from a clinical and financial standpoint. The increasing age of the patient population, associated comorbidities, and the use of newer anticoagulants and cardiac support devices, including left ventricular assist devices, has added further complexity to SB bleeding management.

  [email protected]
  [email protected]
  [email protected]
Speakers Interview